Cytotoxic Lymphocyte Maturation Factor
The present invention relates to a monoclonal or polyclonal antibody directed to an epitope of a cytokine protein called Cytotoxic Lymphocyte Maturation Factor (CLMF) which is produced and synthesized by a human B lymphoblastoid cell line. CLMF synergistically induces in the presence of low concentr...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to a monoclonal or polyclonal antibody directed to an epitope of a cytokine protein called Cytotoxic Lymphocyte Maturation Factor (CLMF) which is produced and synthesized by a human B lymphoblastoid cell line. CLMF synergistically induces in the presence of low concentrations of IL-2 the cytolytic activity of Lymphokine Activated Killer (LAK) cells. CLMF is also capable of stimulating T-cell growth. The present invention also relates to hybridoma cell lines secreting said monoclonal antibody, to processes for the preparation of the said antibodies and to the use of said antibodies for the purification and detection of CLMF protein and for the selective blockade of proliferation and activation of cytotoxic T cells. |
---|